Related references
Note: Only part of the references are listed.Osteopontin and HMGB1: novel regulators of HSC activation
Lee A. Borthwick et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
HMGB1 as biomarker and drug target
Emilie Venereau et al.
PHARMACOLOGICAL RESEARCH (2016)
Quercetin attenuates the activation of hepatic stellate cells and liver fibrosis in mice through modulation of HMGB1-TLR2/4-NF-κB signaling pathways
Xi Li et al.
TOXICOLOGY LETTERS (2016)
The role of high mobility group box 1 (HMGB1) in the pathogenesis of kidney diseases
Qingjie Chen et al.
ACTA PHARMACEUTICA SINICA B (2016)
High Mobility Group Box Protein 1 (HMGB1): The Prototypical Endogenous Danger Molecule
Huan Yang et al.
MOLECULAR MEDICINE (2015)
Endothelial-to-mesenchymal transition induced by Wnt 3a in keloid pathogenesis
Won Jai Lee et al.
WOUND REPAIR AND REGENERATION (2015)
Molecular signalings in keloid disease and current therapeutic approaches from natural based compounds
Thitita Unahabhokha et al.
PHARMACEUTICAL BIOLOGY (2015)
High-mobility Group Box Protein-1, Matrix Metalloproteinases, and Vitamin D in Keloids and Hypertrophic Scars
Dylan E. Lee et al.
PLASTIC AND RECONSTRUCTIVE SURGERY-GLOBAL OPEN (2015)
How is inflammation initiated? Individual influences of IL-1, IL-18 and HMGB1
Peter A. Keyel
CYTOKINE (2014)
Emerging role of HMGB1 in fibrotic diseases
Liu-Cheng Li et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2014)
HMGB1 in health and disease
Rui Kang et al.
MOLECULAR ASPECTS OF MEDICINE (2014)
HMGB1 in Cancer: Good, Bad, or Both?
Rui Kang et al.
CLINICAL CANCER RESEARCH (2013)
Pharmacological treatment for keloids
Chenyu Huang et al.
EXPERT OPINION ON PHARMACOTHERAPY (2013)
Platinum-resistance in ovarian cancer cells is mediated by IL-6 secretion via the increased expression of its target cIAP-2
Sharon Cohen et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
Critical Role of Transforming Growth Factor Beta in Different Phases of Wound Healing
Mohammadreza Pakyari et al.
ADVANCES IN WOUND CARE (2013)
p53/HMGB1 Complexes Regulate Autophagy and Apoptosis
Kristen M. Livesey et al.
CANCER RESEARCH (2012)
HMGB-1 as a Target for Inflammation Controlling
Jose A. Nogueira-Machado et al.
RECENT PATENTS ON ENDOCRINE METABOLIC & IMMUNE DRUG DISCOVERY (2012)
HMGB1 Is a Therapeutic Target for Sterile Inflammation and Infection
Ulf Andersson et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
High-Mobility Group Box Protein 1: A Novel Mediator of Inflammatory-Induced Renal Epithelial-Mesenchymal Transition
Julie Lynch et al.
AMERICAN JOURNAL OF NEPHROLOGY (2010)
Hmgb1 Promotes Wound Healing of 3T3 Mouse Fibroblasts via Rage-Dependent ERK1/2 Activation
Elia Ranzato et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2010)
Epigenetically Altered Wound Healing in Keloid Fibroblasts
Shirley B. Russell et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
HMGB1 release and redox regulates autophagy and apoptosis in cancer cells
D. Tang et al.
ONCOGENE (2010)
Molecular dissection of abnormal wound healing processes resulting in keloid disease
Barbara Shih et al.
WOUND REPAIR AND REGENERATION (2010)
Sterile inflammation: sensing and reacting to damage
Grace Y. Chen et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Genetic susceptibility to raised dermal scarring
J. J. Brown et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Clinical Significance of Serum HMGB-1 and sRAGE Levels in Systemic Sclerosis: Association with Disease Severity
Ayumi Yoshizaki et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2009)
High-mobility group box 1 protein in human and murine skin: Involvement in wound healing
Stefania Straino et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Inhibition of Smad3 expression decreases collagen synthesis in keloid disease fibroblasts
Zimin Wang et al.
JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY (2007)
Prostaglandin E2 inhibition of keloid fibroblast migration, contraction, and transforming growth factor (TGF)-beta 1-induced collagen synthesis
Vlad C. Sandulache et al.
WOUND REPAIR AND REGENERATION (2007)
Modulation of collagen synthesis in keloid fibroblasts by silencing Smad2 with siRNA
Zhongyu Gao et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2006)
Keloid pathogenesis and treatment
A Al-Attar et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2006)
Hypertrophic Response and Keloid Diathesis: Two Very Different Forms of Scar
Andrew Burd et al.
PLASTIC AND RECONSTRUCTIVE SURGERY (2005)
Activation of NFκB signal pathways in keloid fibroblasts
DV Messadi et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2004)
Release of chromatin protein HMGB1 by necrotic cells triggers inflammation
P Scaffidi et al.
NATURE (2002)
Share Paper
